(1) Represents costs incurred to better align capacity to preclinical market demand and reduce overall cost structure. (2) Consists of gain on sale of investments $16,400 and asset impairment charges ...
"Late-Stage Development first quarter revenues grew 16.8% year-on-year to $373 million. Central laboratories and clinical development grew 20% and 18%, respectively, which more than offset a decline ...
Developing a marketing budget is important to ensure proper growth of your business. Your existing budget should be reviewed annually and adjusted depending on your prior year's sales and your goals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results